Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP. Siprashvili Z, et al. Among authors: rieger ke. JAMA. 2016 Nov 1;316(17):1808-1817. doi: 10.1001/jama.2016.15588. JAMA. 2016. PMID: 27802546 Clinical Trial.
Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.
Chiang A, Tan CZ, Kuonen F, Hodgkinson LM, Chiang F, Cho RJ, South AP, Tang JY, Chang ALS, Rieger KE, Oro AE, Sarin KY. Chiang A, et al. Among authors: rieger ke. J Invest Dermatol. 2019 Nov;139(11):2263-2271.e5. doi: 10.1016/j.jid.2019.03.1163. Epub 2019 Jun 15. J Invest Dermatol. 2019. PMID: 31207229 Free PMC article.
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY. Eichstadt S, et al. JCI Insight. 2019 Oct 3;4(19):e130554. doi: 10.1172/jci.insight.130554. JCI Insight. 2019. PMID: 31578311 Free PMC article. Clinical Trial.
LY6D marks pre-existing resistant basosquamous tumor subpopulations.
Haensel D, Gaddam S, Li NY, Gonzalez F, Patel T, Cloutier JM, Sarin KY, Tang JY, Rieger KE, Aasi SZ, Oro AE. Haensel D, et al. Among authors: rieger ke. Nat Commun. 2022 Dec 6;13(1):7520. doi: 10.1038/s41467-022-35020-y. Nat Commun. 2022. PMID: 36473848 Free PMC article.
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
Freites-Martinez A, Kwong BY, Rieger KE, Coit DG, Colevas AD, Lacouture ME. Freites-Martinez A, et al. Among authors: rieger ke. JAMA Dermatol. 2017 Jul 1;153(7):694-697. doi: 10.1001/jamadermatol.2017.0989. JAMA Dermatol. 2017. PMID: 28467522 Free PMC article.
106 results